These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17224907

  • 1. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B, Melnikova VO, Tellez C, Mourad-Zeidan A, Blehm K, Zhao YJ, McCarty M, Adam L, Bar-Eli M.
    Oncogene; 2007 Jun 14; 26(28):4049-58. PubMed ID: 17224907
    [Abstract] [Full Text] [Related]

  • 2. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
    Gershenwald JE, Sumner W, Calderone T, Wang Z, Huang S, Bar-Eli M.
    Oncogene; 2001 Jun 07; 20(26):3363-75. PubMed ID: 11423987
    [Abstract] [Full Text] [Related]

  • 3. Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.
    Fauquette V, Aubert S, Groux-Degroote S, Hemon B, Porchet N, Van Seuningen I, Pigny P.
    Carcinogenesis; 2007 Nov 07; 28(11):2305-12. PubMed ID: 17621592
    [Abstract] [Full Text] [Related]

  • 4. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M.
    Clin Cancer Res; 2005 Jan 01; 11(1):267-72. PubMed ID: 15671555
    [Abstract] [Full Text] [Related]

  • 5. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.
    Gastroenterology; 2007 Mar 01; 132(3):1066-76. PubMed ID: 17383428
    [Abstract] [Full Text] [Related]

  • 6. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M, Troncoso P, Bruns C, Bar-Eli M.
    Clin Cancer Res; 2001 Dec 01; 7(12):4086-95. PubMed ID: 11751506
    [Abstract] [Full Text] [Related]

  • 7. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9).
    Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S.
    Oncogene; 2000 Nov 16; 19(48):5444-52. PubMed ID: 11114721
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
    Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA.
    Cancer Res; 2005 Mar 01; 65(5):1783-91. PubMed ID: 15753375
    [Abstract] [Full Text] [Related]

  • 9. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
    Wenke AK, Grässel S, Moser M, Bosserhoff AK.
    FEBS J; 2009 May 01; 276(9):2494-504. PubMed ID: 19476490
    [Abstract] [Full Text] [Related]

  • 10. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
    Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W.
    Oncogene; 1995 Aug 03; 11(3):475-84. PubMed ID: 7630631
    [Abstract] [Full Text] [Related]

  • 11. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF.
    Mol Cell Biol; 2007 Nov 03; 27(21):7703-17. PubMed ID: 17785436
    [Abstract] [Full Text] [Related]

  • 12. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
    Zhang X, Leung YK, Ho SM.
    Oncogene; 2007 Nov 15; 26(52):7346-54. PubMed ID: 17525739
    [Abstract] [Full Text] [Related]

  • 13. Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells.
    Chen C, Guo L, Shi M, Hu M, Hu M, Yu M, Wang T, Song L, Shen B, Qian L, Guo N.
    Am J Pathol; 2012 Feb 15; 180(2):661-71. PubMed ID: 22182699
    [Abstract] [Full Text] [Related]

  • 14. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
    Mauro L, Catalano S, Bossi G, Pellegrino M, Barone I, Morales S, Giordano C, Bartella V, Casaburi I, Andò S.
    Cancer Res; 2007 Apr 01; 67(7):3412-21. PubMed ID: 17409452
    [Abstract] [Full Text] [Related]

  • 15. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K, Abraham D, Sioud M, Aharinejad S.
    Cancer Res; 2007 Feb 01; 67(3):1038-45. PubMed ID: 17283136
    [Abstract] [Full Text] [Related]

  • 16. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.
    Miyaki M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Takeichi M.
    Oncogene; 1995 Dec 21; 11(12):2547-52. PubMed ID: 8545111
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q, Sun Z, Yang HS.
    Oncogene; 2008 Mar 06; 27(11):1527-35. PubMed ID: 17828298
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
    Yamamoto H, Noura S, Okami J, Uemura M, Takemasa I, Ikeda M, Ishii H, Sekimoto M, Matsuura N, Monden M, Mori M.
    Int J Mol Med; 2008 Dec 06; 22(6):757-61. PubMed ID: 19020773
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
    Llorens A, Rodrigo I, López-Barcons L, Gonzalez-Garrigues M, Lozano E, Vinyals A, Quintanilla M, Cano A, Fabra A.
    Lab Invest; 1998 Sep 06; 78(9):1131-42. PubMed ID: 9759657
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
    Chang TP, Yu SL, Lin SY, Hsiao YJ, Chang GC, Yang PC, Chen JJ.
    Cancer Res; 2010 Feb 15; 70(4):1656-67. PubMed ID: 20145123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.